Clinical trial
Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small…
NCT00003869 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00003869 |
|---|---|
| Title | Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer |
| Official title | Phase III Randomized, Double-Blind Study of CAI and Placebo in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer |
| Intervention type | Drug, Other, Procedure |
| Interventions | carboxyamidotriazole, placebo, quality-of-life assessment, laboratory biomarker analysis |
| Enrollment | 186 |
| Start date | Apr 1, 1999 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Jan 27, 2003 |
| Last update posted | May 20, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: